Company profile
Physiomics PLC
Physiomics | Physiomics - Oncology Drug Development | Pharmaceutical Consulting
Physiomics is a leading oncology drug development consultancy using proprietary state of the artVirtual Tumour technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help them save time and money during pre-clinical and clinical development.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts With Accounts Type Full
Accounts PDF pendingAA | Transaction MzM5ODA2MjcyOWFkaXF6a2N4 | Paper/PDF filed
Published 15 Aug 2024 07:53
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
PREDICT-ONC: Precision Risk Evaluation and G-CSF Dosing for Chemotherapy-Induced Neutropenia Tool
1 Nov 2023 to 31 Mar 2026
Patients with advanced cancers are often treated with chemotherapy which can reduce the effectiveness of the body's own immune system and leave patients exposed to infection. The manufacturers of chemotherapy drugs generally suggest using the same amount of drug for everybody who needs it, however, we know that because everyone is different, people end up...
Prostate Cancer Chemotherapy Precision Dosing APP
1 Apr 2018 to 31 Mar 2019
"Precision medicine heralds a new era of cancer care where each patient receives the right drug at the right dose and time specific to their needs. However, the practice of precision dosing is hampered by a lack of smart dosing algorithms. The choice of chemotherapy dose in the clinical practice is predominantly based on Body Surface Area (BSA) which is d...
DECISION SUPPORT SYSTEMS FOR STRATIFIED CANCER TREATMENT
1 Feb 2017 to 31 Jan 2018
Stratified medicine is a medical model in which patient group data are taken into account to tailor treatment. Various data, including pharmacogenomic data, are used to customise the treatment plan for these patient groups. In oncology, this treatment plan can involve chemotherapy, radiation and surgery. Deciding which treatments to use, and when to apply...
Clinical version of the Physiomics Virtual Tumour
1 Jul 2013 to 31 Mar 2014
Personalised medicine can be broken down into three key questions: which drugs do we give to a particular patient, how much and when? While many companies are seeking to address the first question, dosing and scheduling issues are poorly understood. Attrition rates in oncology remain high, part of the problem being that dosing and scheduling regimens are ...